Amgen Inc. (AMGN) — Analyst outlook / Analyst consensus target is. Based on 38 analyst ratings, the consensus is bullish — 22 Buy, 13 Hold, 3 Sell.
The consensus price target is $347.73 (low: $185.00, high: $432.00), representing a downside of 0.9% from the current price $350.95.
Analysts estimate Earnings Per Share (EPS) of $19.61 and revenue of $33.20B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $7.56 vs est $19.61 (missed -61.4%). 2025: actual $14.33 vs est $21.32 (missed -32.8%). Analyst accuracy: 0%.
AMGN Stock — 12-Month Price Forecast
$347.73
▼ -0.92% Downside
Average Price Target
Based on 38 Wall Street analysts offering 12-month price targets for Amgen Inc., the average price target is $347.73, with a high forecast of $432.00, and a low forecast of $185.00.
The average price target represents a -0.92% change from the last price of $350.95.
Highest Price Target
$432.00
Average Price Target
$347.73
Lowest Price Target
$185.00
AMGN Analyst Ratings
Buy
Based on 38 analysts giving stock ratings to Amgen Inc. in the past 3 months
EPS Estimates — AMGN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $7.56
vs Est $19.61
▼ 159.3% off
2025
Actual $14.33
vs Est $21.32
▼ 48.8% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — AMGN
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $33.424B
vs Est $33.198B
▲ 0.7% off
2025
Actual $36.741B
vs Est $36.358B
▲ 1.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
